13 results
6-K
EX-99.3
IFRX
InflaRx N.V.
23 May 19
Current report (foreign)
8:00am
. operations with opening of corporate office in New York City and hiring of senior executives.
Richard Brudnick, CBO of Codiak BioSciences, appointed
6-K
EX-99.2
IFRX
InflaRx N.V.
11 May 23
Current report (foreign)
8:00am
in The Lancet Respiratory Medicine in September 2022.
II-1
We are preparing for the commercialization of Gohibic (vilobelimab). For this, we are hiring … (vilobelimab) in the future.
For this, we are hiring experts with relevant experience in the commercialization of medical products and are building
6-K
EX-99.2
IFRX
InflaRx N.V.
10 Aug 23
Report of Foreign Private Issuer
8:00am
the EUA, we may be able to generate limited revenues through sales of Gohibic (vilobelimab) to U.S. hospitals under the EUA.
For this, we are hiring
6-K
IFRX
InflaRx N.V.
24 Feb 21
Current report (foreign)
4:16pm
and biotechnology companies for similar personnel. We also experience competition for the hiring of scientific and clinical personnel from universities
20-F/A
2018 FY
IFRX
InflaRx N.V.
29 Mar 19
Annual report (foreign) (amended)
4:23pm
pharmaceutical and biotechnology companies for similar personnel. We also experience competition for the hiring of scientific and clinical personnel … as well as the hiring of more employees. Legal, consulting and audit fees and other expenses increased by €0.5 million to €2.0 million for the year ended
20-F
tw3nl2 8bkai
29 Mar 18
Annual report (foreign)
12:00am
F-1
x73t9ibe bm032vcn
2 May 18
Registration statement (foreign)
7:10am
424B4
o2z5f
7 May 18
Prospectus supplement with pricing info
4:47pm
- Prev
- 1
- Next